Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$19.78 USD
-0.19 (-0.95%)
Updated May 7, 2024 04:00 PM ET
After-Market: $19.80 +0.02 (0.10%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $0.00 | 0.00% |
Earnings Summary
For their last quarter, Myriad Genetics (MYGN) reported earnings of -$0.01 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 90.91%. Look out for MYGN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $0.00 per share, reflecting a year-over-year increase of 100%.
Earnings History
Price & Consensus
Zacks News for MYGN
Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services